March 27, 2008 – The National Institutes of Health (NIH) Clinical Center (CC) recently licensed the TheraDoc clinical solutions, including modules designed to provide advanced tools for active infection surveillance, antimicrobial stewardship, adverse drug event monitoring and documentation, and critical care at the 250-bed treatment and research hospital.
Once implemented, the TheraDoc Expert System will provide an intuitive interface through which context-specific clinical data will be evaluated, confirmed and acted upon. The software will combine patient- and disease-specific data with best-practice guidelines. The maker also said the software will translate the data into actionable patient information and push it securely to clinicians in real-time. TheraDoc said it brings relevant information into a single view, reducing the time it takes to access and utilize data, enabling better decision-making and saving clinicians’ time.
The ability of TheraDoc solutions to help infection control practitioners (ICPs) to clinically identify, confirm and document infections, reduce the time it takes to identify patient specific needs, and create accurate internal and external reports will now be used in a variety of new conditions with CC patients. This will also be true for infectious disease physicians and pharmacists using TheraDoc to optimize the utilization of antimicrobials by monitoring for drug/bug mismatches, renal dosing, IV to PO switch candidates and targeted drugs, the company said.
For more information www.theradoc.com
July 26, 2024 
